Fewer new therapies expected for GI disorders by 2010

Will prescription drugs for gastrointestinal disorders go the way antihistamine medications did when the FDA approved a generic version of Claritin in 2002?

It would appear so, according to "Gastrointestinal Market Outlook to 2010," published by Business Insights, a research and business intelligence consulting company.

Gastroesophageal reflux disease and peptic ulcer disease are among the most highly prevalent diseases, but because of patent expirations over the next five years, this market is forecast to have increasing generic competition and a low level of product introductions through 2010.

Gastrointestinal tract disorders affect millions of people of all ages in all geographic regions, but pharmaceutical research and development strategies in this area have now shifted to therapies for Crohn's disease and agents for irritable bowel syndrome (IBS).

Leading gastrointestinal drugs in development

Source: The Gastrointestinal Market Outlook to 2010

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.


Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky